<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02272530</url>
  </required_header>
  <id_info>
    <org_study_id>Proteome</org_study_id>
    <nct_id>NCT02272530</nct_id>
  </id_info>
  <brief_title>Analysis of Proteome and Pathophysiological Characteristics of Human Blood Cells</brief_title>
  <official_title>Analysis of Proteome and Pathophysiological Characteristics of Human Blood Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate wether change in endothelial nitric oxid synthase of
      blood cells (erythrocytes and peripheral blood mononuclear cells (PBMC)) has an influence on
      development and progression of cardiovascular diseases.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Blood examination</measure>
    <time_frame>baseline</time_frame>
    <description>Following parameters will be examined:
Blood count (red cells, white cells, platelets, hemoglobin, hematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red blood cell distribution width (RDW), mean platelet volume (MPV) )
Creatinin
Urea
Glucose
Glycated hemoglobin (HbA1c)
Cholesterol
Triglyceride
C-reactive Protein
Apolipoprotein</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Protein expression</measure>
    <time_frame>baseline</time_frame>
    <description>Determination with western blot</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asymmetric dimethylarginine (ADMA) and Cytokine</measure>
    <time_frame>baseline</time_frame>
    <description>Determination with enzyme-linked immunosorbent assay (ELISA).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microparticles</measure>
    <time_frame>baseline</time_frame>
    <description>Determination with ELISA and flow cytometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immunocytochemistry</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nitric oxid metabolite and proteins in blood plasma, red blood cells and peripheral blood mononuclear cells (PBMN)</measure>
    <time_frame>baseline</time_frame>
    <description>Determination with reductive chemiluminescence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nitric oxid and reactive oxygen species</measure>
    <time_frame>baseline</time_frame>
    <description>Determination with fluorescence coloring in flow cytometry and fluorescence microscopy</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Red Blood Cell</condition>
  <condition>Peripheral Blood Mononuclear Cell</condition>
  <condition>Endothelial NO-synthase</condition>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>100 healthy volunteers in age of 20-75 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <description>100 patients with stable coronary artery disease and accordingly endothelial dysfunction</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        100 healthy volunteers and 100 patient with stable coronary artery disease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy volunteers

          -  Patients: stable coronary artery disease with accordingly endothelial dysfunction

        Exclusion Criteria:

          -  acute inflammation (CRP&gt;0,5 mg/dl, leucocyte &gt;11000/dl)

          -  malignant diseases

          -  acute or terminated kidney disease

          -  relevant heart failure (NYHA III-IV)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Malte Kelm, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, Pneumology and Angiology, University Hospital Duesseldorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Miriam Cortese-Krott, PhD</last_name>
    <email>Miriam.Cortese@uni-duesseldorf.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Georg Wolff</last_name>
    <email>Georg.Wolff@med.uni-duesseldorf.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Duesseldorf</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miriam Cortese-Krott, PhD</last_name>
      <email>Miriam.Cortese@uni-duesseldorf.de</email>
    </contact>
    <contact_backup>
      <last_name>Georg Wolff</last_name>
      <email>Georg.Wolff@med.uni-duesseldorf.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2014</study_first_submitted>
  <study_first_submitted_qc>October 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2014</study_first_posted>
  <last_update_submitted>October 19, 2016</last_update_submitted>
  <last_update_submitted_qc>October 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endothelial NO-synthase</keyword>
  <keyword>red blood cell</keyword>
  <keyword>erythrocytes</keyword>
  <keyword>Peripheral Blood Mononuclear Cell</keyword>
  <keyword>cardiovascular disease</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

